Detalhe da pesquisa
1.
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions.
CA Cancer J Clin
; 73(6): 620-652, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37329269
2.
RESILIENT part 1: a phase 2 dose-exploration and dose-expansion study of second-line liposomal irinotecan in adults with small cell lung cancer.
Cancer
; 128(9): 1801-1811, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35195913
3.
2020 Innovation-Based Optimism for Lung Cancer Outcomes.
Oncologist
; 26(3): e454-e472, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33179378
4.
From clinical specimens to human cancer preclinical models-a journey the NCI-cell line database-25 years later.
J Cell Biochem
; 121(8-9): 3986-3999, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31803961
5.
New Developments in Neoadjuvant Therapy for Lung Cancer.
Oncology (Williston Park)
; 33(3): 101-6, 109, 2019 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30866032
6.
Long-term safety and survival with gefitinib in select patients with advanced non-small cell lung cancer: Results from the US IRESSA Clinical Access Program (ICAP).
Cancer
; 124(11): 2407-2414, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29579334
7.
HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium.
Cancer
; 123(21): 4099-4105, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28743157
8.
New and emerging targeted treatments in advanced non-small-cell lung cancer.
Lancet
; 388(10048): 1012-24, 2016 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27598681
9.
Extended topoisomerase 1 inhibition through liposomal irinotecan results in improved efficacy over topotecan and irinotecan in models of small-cell lung cancer.
Anticancer Drugs
; 28(10): 1086-1096, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28857767
10.
Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium.
Cancer
; 122(5): 766-72, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26695526
11.
Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.
Cancer
; 121(3): 448-56, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25273224
12.
Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer.
Oncologist
; 20(3): 316-22, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25721120
13.
Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations.
Oncologist
; 20(10): 1175-81, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26330460
14.
How gradual retirement has allowed me to spend more time with family and being physically active.
Clin Adv Hematol Oncol
; 18(1): 17-18, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32511217
15.
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.
JAMA
; 311(19): 1998-2006, 2014 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24846037
16.
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer.
J Clin Oncol
; : JCO2302110, 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38648575
17.
The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC.
JTO Clin Res Rep
; 5(2): 100637, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38361741
18.
Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients.
Cancer
; 119(13): 2383-90, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23585220
19.
Volatile fingerprints of cancer specific genetic mutations.
Nanomedicine
; 9(6): 758-66, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23428987
20.
Broad-Based Molecular Testing for Lung Cancer: Precisely the Time for Precision.
JAMA
; 320(5): 445-446, 2018 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30087992